# A Study in Chinese Mild to Moderate Hypertensive Patients Comparing the Efficacy of Co-Diovan With Diovan.

> **NCT00250562** · PHASE3 · COMPLETED · sponsor: **Novartis** · enrollment: 1171 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** valsartan plus hydrochlorothiazide

## Key facts

- **NCT ID:** NCT00250562
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2006-06
- **Final completion:** 2006-06
- **Target enrollment:** 1171 (ACTUAL)
- **Last updated:** 2017-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00250562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00250562, "A Study in Chinese Mild to Moderate Hypertensive Patients Comparing the Efficacy of Co-Diovan With Diovan.". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00250562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*